Otsuka Holdings Co., Ltd. Share Price Other OTC
Equities
OTSKY
US6891641010
Pharmaceuticals
Sales 2024 * | 2,168B 14.02B 1,170B | Sales 2025 * | 2,153B 13.92B 1,161B | Capitalization | 3,507B 22.67B 1,892B |
---|---|---|---|---|---|
Net income 2024 * | 254B 1.65B 137B | Net income 2025 * | 233B 1.51B 126B | EV / Sales 2024 * | 1.39 x |
Net cash position 2024 * | 496B 3.21B 268B | Net cash position 2025 * | 635B 4.1B 343B | EV / Sales 2025 * | 1.33 x |
P/E ratio 2024 * |
13.7
x | P/E ratio 2025 * |
14.7
x | Employees | - |
Yield 2024 * |
1.86% | Yield 2025 * |
1.93% | Free-Float | 81.41% |
Managers | Title | Age | Since |
---|---|---|---|
Tatsuo Higuchi
CEO | Chief Executive Officer | 73 | 08/08/08 |
Yuko Makino
DFI | Director of Finance/CFO | 62 | 01/15/01 |
Ichiro Otsuka
CHM | Chairman | 59 | 08/08/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tatsuo Higuchi
CEO | Chief Executive Officer | 73 | 08/08/08 |
Ichiro Otsuka
CHM | Chairman | 59 | 08/08/08 |
Director/Board Member | 57 | 30/17/30 |
1st Jan change | Capi. | |
---|---|---|
+20.32% | 43.95B | |
+11.68% | 14.71B | |
+11.31% | 13.77B | |
+42.32% | 12.3B | |
-8.70% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.75% | 5.48B | |
-3.58% | 4.75B |